Eastern Bank Amgen Inc Transaction History

Eastern Bank

$5.44 Billion
Q3 2024

A detailed history of Eastern Bank transactions in Amgen Inc stock. As of the latest transaction made, Eastern Bank holds 7,354 shares of AMGN stock, worth $2.05 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

7,354

Previous 1,907 285.63%

Holding current value

$2.05 Million

Previous $595,000 298.15%

% of portfolio

0.04%

Previous 0.02%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	BUY	$309.38 - $337.38 $1.69 Million - $1.84 Million	5,447 Added 285.63%	7,354 $2.37 Million
Q2 2024 Jul 23, 2024	SELL	$262.75 - $319.31 $30,216 - $36,720	-115 Reduced 5.69%	1,907 $595,000
Q1 2024 May 09, 2024	SELL	$268.87 - $324.56 $36,835 - $44,464	-137 Reduced 6.35%	2,022 $574,000
Q4 2023 Jan 25, 2024	BUY	$255.7 - $288.46 $35,030 - $39,519	137 Added 6.78%	2,159 $621,000
Q2 2023 Jul 19, 2023	SELL	$214.27 - $253.37 $74,994 - $88,679	-350 Reduced 14.76%	2,022 $448,000
Q1 2023 Apr 19, 2023	SELL	$225.79 - $275.2 $4,515 - $5,504	-20 Reduced 0.84%	2,372 $573,000
Q4 2022 Jan 24, 2023	BUY	$229.03 - $291.01 $3,664 - $4,656	16 Added 0.67%	2,392 $0
Q2 2022 Jul 20, 2022	BUY	$230.71 - $256.74 $922 - $1,026	4 Added 0.17%	2,376 $578,000
Q1 2022 Apr 21, 2022	SELL	$219.27 - $242.57 $58,764 - $65,008	-268 Reduced 10.15%	2,372 $574,000
Q4 2021 Jan 26, 2022	BUY	$198.88 - $227.6 $66,624 - $76,246	335 Added 14.53%	2,640 $594,000
Q4 2020 Jan 20, 2021	SELL	$216.38 - $257.67 $108,190 - $128,835	-500 Reduced 17.83%	2,305 $530,000
Q3 2020 Oct 30, 2020	SELL	$234.65 - $260.95 $469 - $521	-2 Reduced 0.07%	2,805 $713,000
Q2 2020 Jul 21, 2020	SELL	$197.81 - $242.74 $41,935 - $51,460	-212 Reduced 7.02%	2,807 $662,000
Q1 2020 Apr 27, 2020	SELL	$182.24 - $241.7 $8,747 - $11,601	-48 Reduced 1.57%	3,019 $612,000
Q4 2019 Feb 04, 2020	BUY	$189.21 - $243.2 $1,324 - $1,702	7 Added 0.23%	3,067 $739,000
Q2 2019 Jul 24, 2019	SELL	$166.7 - $195.41 $6,668 - $7,816	-40 Reduced 1.29%	3,060 $563,000
Q1 2019 Apr 18, 2019	SELL	$180.87 - $203.88 $27,492 - $30,989	-152 Reduced 4.67%	3,100 $589,000
Q4 2018 Jan 18, 2019	SELL	$178.4 - $208.25 $32,825 - $38,318	-184 Reduced 5.36%	3,252 $633,000
Q3 2018 Oct 16, 2018	SELL	$185.29 - $208.89 $24,643 - $27,782	-133 Reduced 3.73%	3,436 $713,000
Q2 2018 Jul 18, 2018	SELL	$166.05 - $186.51 $180,496 - $202,736	-1,087 Reduced 23.35%	3,569 $659,000
Q1 2018 Apr 09, 2018	SELL	$169.43 - $198.0 $623,671 - $728,838	-3,681 Reduced 44.15%	4,656 $794,000
Q4 2017 Jan 22, 2018	SELL	$168.79 - $188.59 $10.3 Million - $11.5 Million	-60,956 Reduced 87.97%	8,337 $1.45 Million
Q3 2017 Oct 24, 2017	BUY	$167.29 - $191.0 $11.6 Million - $13.2 Million	69,293	69,293 $12.9 Million

Others Institutions Holding AMGN

# of Institutions

3,119

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eastern Bank, based on Form 13F filings with the SEC.

News

Stay updated on Eastern Bank with notifications on news.

Account